Journal of Translational Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2230093, encodeId=86b42230093c0, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;实验验证;生信分析 经验分享：已经10天了还是new submission，我真服了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b789465039, createdName=ms2000000351369451, createdTime=Thu Oct 10 09:17:34 CST 2024, time=2024-10-10, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2229455, encodeId=03602229455bd, content=9.24投稿，一直都是New Submission的状态，看大家好像都是New submission的状态持续了很久，这个到底是什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ed95231680, createdName=147a0654m16暂无昵称, createdTime=Sat Oct 05 22:12:13 CST 2024, time=2024-10-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2231705, encodeId=83fd2231e051f, content=3.26 New Submission； 3.29 Reviwerers Assigned; 4.18Reviwerers Assigned; 7.10 Reviwerers Assigned; 7.16 Reviwerers Assigned; 7.25 Reviews Completed; 8.5 Revision; 8.17 Back; 8.26 Under Review; 9.11 Reviews Completed; 9.16 Editor Assigned; 9.18 Accepted., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230904/40692e5b0b4845d79b7286fcdec4d98b/e529a33c15604ed0b99794e72bf3a6ac.jpg, createdBy=a29c4739753, createdName=Best wishes, createdTime=Sat Oct 19 13:06:15 CST 2024, time=2024-10-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2231068, encodeId=bbf122310687b, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：好慢呀，已经3周了都还是New Submission，不知道到底有没有处理稿件，Your research上都还查不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=617e5398444, createdName=ms8000002010343827, createdTime=Tue Oct 15 17:25:07 CST 2024, time=2024-10-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2231710, encodeId=96012231e10a7, content=投稿命中率:5.0 经验分享：9.27投稿，一直是new submission状态，10.19被拒，没有理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53579476156, createdName=ms3000000427064285, createdTime=Sat Oct 19 13:55:27 CST 2024, time=2024-10-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2231278, encodeId=c34422312e869, content=偏重的研究方向：肿瘤 经验分享：09/26 submission 10/15 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c67b9417863, createdName=ms7000001135825628, createdTime=Thu Oct 17 07:51:42 CST 2024, time=2024-10-17, status=1, ipAttribution=日本), GetPortalCommentsPageByObjectIdResponse(id=2230967, encodeId=92e6223096e41, content=审稿速度:6.0 偏重的研究方向：转化医学 经验分享：9.26投稿一直new submission 20天了没动静，写了一次催稿信，没回复 10.15 写了撤稿，蹲后续, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b998153454, createdName=ms2000002105671892, createdTime=Tue Oct 15 08:19:11 CST 2024, time=2024-10-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2224693, encodeId=3fd12224693c9, content=请问下大伙这个杂志new manuscript要多长时间，我的已经12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44ca5480638, createdName=ms7000000631111361, createdTime=Sun Sep 08 14:44:25 CST 2024, time=2024-09-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2230765, encodeId=ef382230e658b, content=已经22天了还是new submission ，是什么情况呀，也太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80059409596, createdName=ms5000000686904291, createdTime=Mon Oct 14 09:43:06 CST 2024, time=2024-10-14, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2228040, encodeId=7a872228040df, content=偏重的研究方向：内科 经验分享：请问大家一审修回后under review一周又变成reviewers assigned这是为什么啊，是有个审稿人拒了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55475510121, createdName=beryllee, createdTime=Fri Sep 27 19:34:13 CST 2024, time=2024-09-27, status=1, ipAttribution=浙江省)]

2024-10-10 ms2000000351369451 来自天津

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤;实验验证;生信分析
经验分享：已经10天了还是new submission，我真服了

17 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2230093, encodeId=86b42230093c0, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;实验验证;生信分析 经验分享：已经10天了还是new submission，我真服了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b789465039, createdName=ms2000000351369451, createdTime=Thu Oct 10 09:17:34 CST 2024, time=2024-10-10, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2229455, encodeId=03602229455bd, content=9.24投稿，一直都是New Submission的状态，看大家好像都是New submission的状态持续了很久，这个到底是什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ed95231680, createdName=147a0654m16暂无昵称, createdTime=Sat Oct 05 22:12:13 CST 2024, time=2024-10-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2231705, encodeId=83fd2231e051f, content=3.26 New Submission； 3.29 Reviwerers Assigned; 4.18Reviwerers Assigned; 7.10 Reviwerers Assigned; 7.16 Reviwerers Assigned; 7.25 Reviews Completed; 8.5 Revision; 8.17 Back; 8.26 Under Review; 9.11 Reviews Completed; 9.16 Editor Assigned; 9.18 Accepted., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230904/40692e5b0b4845d79b7286fcdec4d98b/e529a33c15604ed0b99794e72bf3a6ac.jpg, createdBy=a29c4739753, createdName=Best wishes, createdTime=Sat Oct 19 13:06:15 CST 2024, time=2024-10-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2231068, encodeId=bbf122310687b, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：好慢呀，已经3周了都还是New Submission，不知道到底有没有处理稿件，Your research上都还查不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=617e5398444, createdName=ms8000002010343827, createdTime=Tue Oct 15 17:25:07 CST 2024, time=2024-10-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2231710, encodeId=96012231e10a7, content=投稿命中率:5.0 经验分享：9.27投稿，一直是new submission状态，10.19被拒，没有理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53579476156, createdName=ms3000000427064285, createdTime=Sat Oct 19 13:55:27 CST 2024, time=2024-10-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2231278, encodeId=c34422312e869, content=偏重的研究方向：肿瘤 经验分享：09/26 submission 10/15 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c67b9417863, createdName=ms7000001135825628, createdTime=Thu Oct 17 07:51:42 CST 2024, time=2024-10-17, status=1, ipAttribution=日本), GetPortalCommentsPageByObjectIdResponse(id=2230967, encodeId=92e6223096e41, content=审稿速度:6.0 偏重的研究方向：转化医学 经验分享：9.26投稿一直new submission 20天了没动静，写了一次催稿信，没回复 10.15 写了撤稿，蹲后续, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b998153454, createdName=ms2000002105671892, createdTime=Tue Oct 15 08:19:11 CST 2024, time=2024-10-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2224693, encodeId=3fd12224693c9, content=请问下大伙这个杂志new manuscript要多长时间，我的已经12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44ca5480638, createdName=ms7000000631111361, createdTime=Sun Sep 08 14:44:25 CST 2024, time=2024-09-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2230765, encodeId=ef382230e658b, content=已经22天了还是new submission ，是什么情况呀，也太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80059409596, createdName=ms5000000686904291, createdTime=Mon Oct 14 09:43:06 CST 2024, time=2024-10-14, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2228040, encodeId=7a872228040df, content=偏重的研究方向：内科 经验分享：请问大家一审修回后under review一周又变成reviewers assigned这是为什么啊，是有个审稿人拒了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55475510121, createdName=beryllee, createdTime=Fri Sep 27 19:34:13 CST 2024, time=2024-09-27, status=1, ipAttribution=浙江省)]

2024-10-05 147a0654m16暂无昵称来自北京

9.24投稿，一直都是New Submission的状态，看大家好像都是New submission的状态持续了很久，这个到底是什么情况啊？

14 19

展开19条回复

[GetPortalCommentsPageByObjectIdResponse(id=2230093, encodeId=86b42230093c0, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;实验验证;生信分析 经验分享：已经10天了还是new submission，我真服了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b789465039, createdName=ms2000000351369451, createdTime=Thu Oct 10 09:17:34 CST 2024, time=2024-10-10, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2229455, encodeId=03602229455bd, content=9.24投稿，一直都是New Submission的状态，看大家好像都是New submission的状态持续了很久，这个到底是什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ed95231680, createdName=147a0654m16暂无昵称, createdTime=Sat Oct 05 22:12:13 CST 2024, time=2024-10-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2231705, encodeId=83fd2231e051f, content=3.26 New Submission； 3.29 Reviwerers Assigned; 4.18Reviwerers Assigned; 7.10 Reviwerers Assigned; 7.16 Reviwerers Assigned; 7.25 Reviews Completed; 8.5 Revision; 8.17 Back; 8.26 Under Review; 9.11 Reviews Completed; 9.16 Editor Assigned; 9.18 Accepted., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230904/40692e5b0b4845d79b7286fcdec4d98b/e529a33c15604ed0b99794e72bf3a6ac.jpg, createdBy=a29c4739753, createdName=Best wishes, createdTime=Sat Oct 19 13:06:15 CST 2024, time=2024-10-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2231068, encodeId=bbf122310687b, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：好慢呀，已经3周了都还是New Submission，不知道到底有没有处理稿件，Your research上都还查不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=617e5398444, createdName=ms8000002010343827, createdTime=Tue Oct 15 17:25:07 CST 2024, time=2024-10-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2231710, encodeId=96012231e10a7, content=投稿命中率:5.0 经验分享：9.27投稿，一直是new submission状态，10.19被拒，没有理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53579476156, createdName=ms3000000427064285, createdTime=Sat Oct 19 13:55:27 CST 2024, time=2024-10-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2231278, encodeId=c34422312e869, content=偏重的研究方向：肿瘤 经验分享：09/26 submission 10/15 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c67b9417863, createdName=ms7000001135825628, createdTime=Thu Oct 17 07:51:42 CST 2024, time=2024-10-17, status=1, ipAttribution=日本), GetPortalCommentsPageByObjectIdResponse(id=2230967, encodeId=92e6223096e41, content=审稿速度:6.0 偏重的研究方向：转化医学 经验分享：9.26投稿一直new submission 20天了没动静，写了一次催稿信，没回复 10.15 写了撤稿，蹲后续, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b998153454, createdName=ms2000002105671892, createdTime=Tue Oct 15 08:19:11 CST 2024, time=2024-10-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2224693, encodeId=3fd12224693c9, content=请问下大伙这个杂志new manuscript要多长时间，我的已经12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44ca5480638, createdName=ms7000000631111361, createdTime=Sun Sep 08 14:44:25 CST 2024, time=2024-09-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2230765, encodeId=ef382230e658b, content=已经22天了还是new submission ，是什么情况呀，也太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80059409596, createdName=ms5000000686904291, createdTime=Mon Oct 14 09:43:06 CST 2024, time=2024-10-14, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2228040, encodeId=7a872228040df, content=偏重的研究方向：内科 经验分享：请问大家一审修回后under review一周又变成reviewers assigned这是为什么啊，是有个审稿人拒了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55475510121, createdName=beryllee, createdTime=Fri Sep 27 19:34:13 CST 2024, time=2024-09-27, status=1, ipAttribution=浙江省)]

2024-10-19 Best wishes 来自广东省

3.26 New Submission；
3.29 Reviwerers Assigned;
4.18Reviwerers Assigned;
7.10 Reviwerers Assigned;
7.16 Reviwerers Assigned;
7.25 Reviews Completed;
8.5 Revision;
8.17 Back;
8.26 Under Review;
9.11 Reviews Completed;
9.16 Editor Assigned;
9.18 Accepted.

7 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2230093, encodeId=86b42230093c0, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;实验验证;生信分析 经验分享：已经10天了还是new submission，我真服了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b789465039, createdName=ms2000000351369451, createdTime=Thu Oct 10 09:17:34 CST 2024, time=2024-10-10, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2229455, encodeId=03602229455bd, content=9.24投稿，一直都是New Submission的状态，看大家好像都是New submission的状态持续了很久，这个到底是什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ed95231680, createdName=147a0654m16暂无昵称, createdTime=Sat Oct 05 22:12:13 CST 2024, time=2024-10-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2231705, encodeId=83fd2231e051f, content=3.26 New Submission； 3.29 Reviwerers Assigned; 4.18Reviwerers Assigned; 7.10 Reviwerers Assigned; 7.16 Reviwerers Assigned; 7.25 Reviews Completed; 8.5 Revision; 8.17 Back; 8.26 Under Review; 9.11 Reviews Completed; 9.16 Editor Assigned; 9.18 Accepted., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230904/40692e5b0b4845d79b7286fcdec4d98b/e529a33c15604ed0b99794e72bf3a6ac.jpg, createdBy=a29c4739753, createdName=Best wishes, createdTime=Sat Oct 19 13:06:15 CST 2024, time=2024-10-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2231068, encodeId=bbf122310687b, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：好慢呀，已经3周了都还是New Submission，不知道到底有没有处理稿件，Your research上都还查不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=617e5398444, createdName=ms8000002010343827, createdTime=Tue Oct 15 17:25:07 CST 2024, time=2024-10-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2231710, encodeId=96012231e10a7, content=投稿命中率:5.0 经验分享：9.27投稿，一直是new submission状态，10.19被拒，没有理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53579476156, createdName=ms3000000427064285, createdTime=Sat Oct 19 13:55:27 CST 2024, time=2024-10-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2231278, encodeId=c34422312e869, content=偏重的研究方向：肿瘤 经验分享：09/26 submission 10/15 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c67b9417863, createdName=ms7000001135825628, createdTime=Thu Oct 17 07:51:42 CST 2024, time=2024-10-17, status=1, ipAttribution=日本), GetPortalCommentsPageByObjectIdResponse(id=2230967, encodeId=92e6223096e41, content=审稿速度:6.0 偏重的研究方向：转化医学 经验分享：9.26投稿一直new submission 20天了没动静，写了一次催稿信，没回复 10.15 写了撤稿，蹲后续, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b998153454, createdName=ms2000002105671892, createdTime=Tue Oct 15 08:19:11 CST 2024, time=2024-10-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2224693, encodeId=3fd12224693c9, content=请问下大伙这个杂志new manuscript要多长时间，我的已经12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44ca5480638, createdName=ms7000000631111361, createdTime=Sun Sep 08 14:44:25 CST 2024, time=2024-09-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2230765, encodeId=ef382230e658b, content=已经22天了还是new submission ，是什么情况呀，也太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80059409596, createdName=ms5000000686904291, createdTime=Mon Oct 14 09:43:06 CST 2024, time=2024-10-14, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2228040, encodeId=7a872228040df, content=偏重的研究方向：内科 经验分享：请问大家一审修回后under review一周又变成reviewers assigned这是为什么啊，是有个审稿人拒了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55475510121, createdName=beryllee, createdTime=Fri Sep 27 19:34:13 CST 2024, time=2024-09-27, status=1, ipAttribution=浙江省)]

2024-10-15 ms8000002010343827 来自广东省

审稿速度:3.0 | 投稿命中率:50.0
经验分享：好慢呀，已经3周了都还是New Submission，不知道到底有没有处理稿件，Your research上都还查不到

7 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2230093, encodeId=86b42230093c0, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;实验验证;生信分析 经验分享：已经10天了还是new submission，我真服了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b789465039, createdName=ms2000000351369451, createdTime=Thu Oct 10 09:17:34 CST 2024, time=2024-10-10, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2229455, encodeId=03602229455bd, content=9.24投稿，一直都是New Submission的状态，看大家好像都是New submission的状态持续了很久，这个到底是什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ed95231680, createdName=147a0654m16暂无昵称, createdTime=Sat Oct 05 22:12:13 CST 2024, time=2024-10-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2231705, encodeId=83fd2231e051f, content=3.26 New Submission； 3.29 Reviwerers Assigned; 4.18Reviwerers Assigned; 7.10 Reviwerers Assigned; 7.16 Reviwerers Assigned; 7.25 Reviews Completed; 8.5 Revision; 8.17 Back; 8.26 Under Review; 9.11 Reviews Completed; 9.16 Editor Assigned; 9.18 Accepted., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230904/40692e5b0b4845d79b7286fcdec4d98b/e529a33c15604ed0b99794e72bf3a6ac.jpg, createdBy=a29c4739753, createdName=Best wishes, createdTime=Sat Oct 19 13:06:15 CST 2024, time=2024-10-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2231068, encodeId=bbf122310687b, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：好慢呀，已经3周了都还是New Submission，不知道到底有没有处理稿件，Your research上都还查不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=617e5398444, createdName=ms8000002010343827, createdTime=Tue Oct 15 17:25:07 CST 2024, time=2024-10-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2231710, encodeId=96012231e10a7, content=投稿命中率:5.0 经验分享：9.27投稿，一直是new submission状态，10.19被拒，没有理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53579476156, createdName=ms3000000427064285, createdTime=Sat Oct 19 13:55:27 CST 2024, time=2024-10-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2231278, encodeId=c34422312e869, content=偏重的研究方向：肿瘤 经验分享：09/26 submission 10/15 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c67b9417863, createdName=ms7000001135825628, createdTime=Thu Oct 17 07:51:42 CST 2024, time=2024-10-17, status=1, ipAttribution=日本), GetPortalCommentsPageByObjectIdResponse(id=2230967, encodeId=92e6223096e41, content=审稿速度:6.0 偏重的研究方向：转化医学 经验分享：9.26投稿一直new submission 20天了没动静，写了一次催稿信，没回复 10.15 写了撤稿，蹲后续, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b998153454, createdName=ms2000002105671892, createdTime=Tue Oct 15 08:19:11 CST 2024, time=2024-10-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2224693, encodeId=3fd12224693c9, content=请问下大伙这个杂志new manuscript要多长时间，我的已经12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44ca5480638, createdName=ms7000000631111361, createdTime=Sun Sep 08 14:44:25 CST 2024, time=2024-09-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2230765, encodeId=ef382230e658b, content=已经22天了还是new submission ，是什么情况呀，也太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80059409596, createdName=ms5000000686904291, createdTime=Mon Oct 14 09:43:06 CST 2024, time=2024-10-14, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2228040, encodeId=7a872228040df, content=偏重的研究方向：内科 经验分享：请问大家一审修回后under review一周又变成reviewers assigned这是为什么啊，是有个审稿人拒了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55475510121, createdName=beryllee, createdTime=Fri Sep 27 19:34:13 CST 2024, time=2024-09-27, status=1, ipAttribution=浙江省)]

2024-10-19 ms3000000427064285 来自重庆

投稿命中率:5.0
经验分享：9.27投稿，一直是new submission状态，10.19被拒，没有理由

5 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2230093, encodeId=86b42230093c0, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;实验验证;生信分析 经验分享：已经10天了还是new submission，我真服了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b789465039, createdName=ms2000000351369451, createdTime=Thu Oct 10 09:17:34 CST 2024, time=2024-10-10, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2229455, encodeId=03602229455bd, content=9.24投稿，一直都是New Submission的状态，看大家好像都是New submission的状态持续了很久，这个到底是什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ed95231680, createdName=147a0654m16暂无昵称, createdTime=Sat Oct 05 22:12:13 CST 2024, time=2024-10-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2231705, encodeId=83fd2231e051f, content=3.26 New Submission； 3.29 Reviwerers Assigned; 4.18Reviwerers Assigned; 7.10 Reviwerers Assigned; 7.16 Reviwerers Assigned; 7.25 Reviews Completed; 8.5 Revision; 8.17 Back; 8.26 Under Review; 9.11 Reviews Completed; 9.16 Editor Assigned; 9.18 Accepted., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230904/40692e5b0b4845d79b7286fcdec4d98b/e529a33c15604ed0b99794e72bf3a6ac.jpg, createdBy=a29c4739753, createdName=Best wishes, createdTime=Sat Oct 19 13:06:15 CST 2024, time=2024-10-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2231068, encodeId=bbf122310687b, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：好慢呀，已经3周了都还是New Submission，不知道到底有没有处理稿件，Your research上都还查不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=617e5398444, createdName=ms8000002010343827, createdTime=Tue Oct 15 17:25:07 CST 2024, time=2024-10-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2231710, encodeId=96012231e10a7, content=投稿命中率:5.0 经验分享：9.27投稿，一直是new submission状态，10.19被拒，没有理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53579476156, createdName=ms3000000427064285, createdTime=Sat Oct 19 13:55:27 CST 2024, time=2024-10-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2231278, encodeId=c34422312e869, content=偏重的研究方向：肿瘤 经验分享：09/26 submission 10/15 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c67b9417863, createdName=ms7000001135825628, createdTime=Thu Oct 17 07:51:42 CST 2024, time=2024-10-17, status=1, ipAttribution=日本), GetPortalCommentsPageByObjectIdResponse(id=2230967, encodeId=92e6223096e41, content=审稿速度:6.0 偏重的研究方向：转化医学 经验分享：9.26投稿一直new submission 20天了没动静，写了一次催稿信，没回复 10.15 写了撤稿，蹲后续, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b998153454, createdName=ms2000002105671892, createdTime=Tue Oct 15 08:19:11 CST 2024, time=2024-10-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2224693, encodeId=3fd12224693c9, content=请问下大伙这个杂志new manuscript要多长时间，我的已经12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44ca5480638, createdName=ms7000000631111361, createdTime=Sun Sep 08 14:44:25 CST 2024, time=2024-09-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2230765, encodeId=ef382230e658b, content=已经22天了还是new submission ，是什么情况呀，也太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80059409596, createdName=ms5000000686904291, createdTime=Mon Oct 14 09:43:06 CST 2024, time=2024-10-14, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2228040, encodeId=7a872228040df, content=偏重的研究方向：内科 经验分享：请问大家一审修回后under review一周又变成reviewers assigned这是为什么啊，是有个审稿人拒了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55475510121, createdName=beryllee, createdTime=Fri Sep 27 19:34:13 CST 2024, time=2024-09-27, status=1, ipAttribution=浙江省)]

2024-10-17 ms7000001135825628 来自日本

偏重的研究方向：肿瘤
经验分享：09/26 submission 10/15 under review

6 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2230093, encodeId=86b42230093c0, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;实验验证;生信分析 经验分享：已经10天了还是new submission，我真服了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b789465039, createdName=ms2000000351369451, createdTime=Thu Oct 10 09:17:34 CST 2024, time=2024-10-10, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2229455, encodeId=03602229455bd, content=9.24投稿，一直都是New Submission的状态，看大家好像都是New submission的状态持续了很久，这个到底是什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ed95231680, createdName=147a0654m16暂无昵称, createdTime=Sat Oct 05 22:12:13 CST 2024, time=2024-10-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2231705, encodeId=83fd2231e051f, content=3.26 New Submission； 3.29 Reviwerers Assigned; 4.18Reviwerers Assigned; 7.10 Reviwerers Assigned; 7.16 Reviwerers Assigned; 7.25 Reviews Completed; 8.5 Revision; 8.17 Back; 8.26 Under Review; 9.11 Reviews Completed; 9.16 Editor Assigned; 9.18 Accepted., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230904/40692e5b0b4845d79b7286fcdec4d98b/e529a33c15604ed0b99794e72bf3a6ac.jpg, createdBy=a29c4739753, createdName=Best wishes, createdTime=Sat Oct 19 13:06:15 CST 2024, time=2024-10-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2231068, encodeId=bbf122310687b, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：好慢呀，已经3周了都还是New Submission，不知道到底有没有处理稿件，Your research上都还查不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=617e5398444, createdName=ms8000002010343827, createdTime=Tue Oct 15 17:25:07 CST 2024, time=2024-10-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2231710, encodeId=96012231e10a7, content=投稿命中率:5.0 经验分享：9.27投稿，一直是new submission状态，10.19被拒，没有理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53579476156, createdName=ms3000000427064285, createdTime=Sat Oct 19 13:55:27 CST 2024, time=2024-10-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2231278, encodeId=c34422312e869, content=偏重的研究方向：肿瘤 经验分享：09/26 submission 10/15 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c67b9417863, createdName=ms7000001135825628, createdTime=Thu Oct 17 07:51:42 CST 2024, time=2024-10-17, status=1, ipAttribution=日本), GetPortalCommentsPageByObjectIdResponse(id=2230967, encodeId=92e6223096e41, content=审稿速度:6.0 偏重的研究方向：转化医学 经验分享：9.26投稿一直new submission 20天了没动静，写了一次催稿信，没回复 10.15 写了撤稿，蹲后续, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b998153454, createdName=ms2000002105671892, createdTime=Tue Oct 15 08:19:11 CST 2024, time=2024-10-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2224693, encodeId=3fd12224693c9, content=请问下大伙这个杂志new manuscript要多长时间，我的已经12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44ca5480638, createdName=ms7000000631111361, createdTime=Sun Sep 08 14:44:25 CST 2024, time=2024-09-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2230765, encodeId=ef382230e658b, content=已经22天了还是new submission ，是什么情况呀，也太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80059409596, createdName=ms5000000686904291, createdTime=Mon Oct 14 09:43:06 CST 2024, time=2024-10-14, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2228040, encodeId=7a872228040df, content=偏重的研究方向：内科 经验分享：请问大家一审修回后under review一周又变成reviewers assigned这是为什么啊，是有个审稿人拒了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55475510121, createdName=beryllee, createdTime=Fri Sep 27 19:34:13 CST 2024, time=2024-09-27, status=1, ipAttribution=浙江省)]

2024-10-15 ms2000002105671892 来自陕西省

审稿速度:6.0
偏重的研究方向：转化医学
经验分享：9.26投稿一直new submission 20天了没动静，写了一次催稿信，没回复 10.15 写了撤稿，蹲后续

10 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2230093, encodeId=86b42230093c0, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;实验验证;生信分析 经验分享：已经10天了还是new submission，我真服了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b789465039, createdName=ms2000000351369451, createdTime=Thu Oct 10 09:17:34 CST 2024, time=2024-10-10, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2229455, encodeId=03602229455bd, content=9.24投稿，一直都是New Submission的状态，看大家好像都是New submission的状态持续了很久，这个到底是什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ed95231680, createdName=147a0654m16暂无昵称, createdTime=Sat Oct 05 22:12:13 CST 2024, time=2024-10-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2231705, encodeId=83fd2231e051f, content=3.26 New Submission； 3.29 Reviwerers Assigned; 4.18Reviwerers Assigned; 7.10 Reviwerers Assigned; 7.16 Reviwerers Assigned; 7.25 Reviews Completed; 8.5 Revision; 8.17 Back; 8.26 Under Review; 9.11 Reviews Completed; 9.16 Editor Assigned; 9.18 Accepted., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230904/40692e5b0b4845d79b7286fcdec4d98b/e529a33c15604ed0b99794e72bf3a6ac.jpg, createdBy=a29c4739753, createdName=Best wishes, createdTime=Sat Oct 19 13:06:15 CST 2024, time=2024-10-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2231068, encodeId=bbf122310687b, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：好慢呀，已经3周了都还是New Submission，不知道到底有没有处理稿件，Your research上都还查不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=617e5398444, createdName=ms8000002010343827, createdTime=Tue Oct 15 17:25:07 CST 2024, time=2024-10-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2231710, encodeId=96012231e10a7, content=投稿命中率:5.0 经验分享：9.27投稿，一直是new submission状态，10.19被拒，没有理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53579476156, createdName=ms3000000427064285, createdTime=Sat Oct 19 13:55:27 CST 2024, time=2024-10-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2231278, encodeId=c34422312e869, content=偏重的研究方向：肿瘤 经验分享：09/26 submission 10/15 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c67b9417863, createdName=ms7000001135825628, createdTime=Thu Oct 17 07:51:42 CST 2024, time=2024-10-17, status=1, ipAttribution=日本), GetPortalCommentsPageByObjectIdResponse(id=2230967, encodeId=92e6223096e41, content=审稿速度:6.0 偏重的研究方向：转化医学 经验分享：9.26投稿一直new submission 20天了没动静，写了一次催稿信，没回复 10.15 写了撤稿，蹲后续, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b998153454, createdName=ms2000002105671892, createdTime=Tue Oct 15 08:19:11 CST 2024, time=2024-10-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2224693, encodeId=3fd12224693c9, content=请问下大伙这个杂志new manuscript要多长时间，我的已经12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44ca5480638, createdName=ms7000000631111361, createdTime=Sun Sep 08 14:44:25 CST 2024, time=2024-09-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2230765, encodeId=ef382230e658b, content=已经22天了还是new submission ，是什么情况呀，也太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80059409596, createdName=ms5000000686904291, createdTime=Mon Oct 14 09:43:06 CST 2024, time=2024-10-14, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2228040, encodeId=7a872228040df, content=偏重的研究方向：内科 经验分享：请问大家一审修回后under review一周又变成reviewers assigned这是为什么啊，是有个审稿人拒了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55475510121, createdName=beryllee, createdTime=Fri Sep 27 19:34:13 CST 2024, time=2024-09-27, status=1, ipAttribution=浙江省)]

2024-09-08 ms7000000631111361 来自湖北省

请问下大伙这个杂志new manuscript要多长时间，我的已经12天了

22 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2230093, encodeId=86b42230093c0, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;实验验证;生信分析 经验分享：已经10天了还是new submission，我真服了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b789465039, createdName=ms2000000351369451, createdTime=Thu Oct 10 09:17:34 CST 2024, time=2024-10-10, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2229455, encodeId=03602229455bd, content=9.24投稿，一直都是New Submission的状态，看大家好像都是New submission的状态持续了很久，这个到底是什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ed95231680, createdName=147a0654m16暂无昵称, createdTime=Sat Oct 05 22:12:13 CST 2024, time=2024-10-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2231705, encodeId=83fd2231e051f, content=3.26 New Submission； 3.29 Reviwerers Assigned; 4.18Reviwerers Assigned; 7.10 Reviwerers Assigned; 7.16 Reviwerers Assigned; 7.25 Reviews Completed; 8.5 Revision; 8.17 Back; 8.26 Under Review; 9.11 Reviews Completed; 9.16 Editor Assigned; 9.18 Accepted., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230904/40692e5b0b4845d79b7286fcdec4d98b/e529a33c15604ed0b99794e72bf3a6ac.jpg, createdBy=a29c4739753, createdName=Best wishes, createdTime=Sat Oct 19 13:06:15 CST 2024, time=2024-10-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2231068, encodeId=bbf122310687b, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：好慢呀，已经3周了都还是New Submission，不知道到底有没有处理稿件，Your research上都还查不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=617e5398444, createdName=ms8000002010343827, createdTime=Tue Oct 15 17:25:07 CST 2024, time=2024-10-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2231710, encodeId=96012231e10a7, content=投稿命中率:5.0 经验分享：9.27投稿，一直是new submission状态，10.19被拒，没有理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53579476156, createdName=ms3000000427064285, createdTime=Sat Oct 19 13:55:27 CST 2024, time=2024-10-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2231278, encodeId=c34422312e869, content=偏重的研究方向：肿瘤 经验分享：09/26 submission 10/15 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c67b9417863, createdName=ms7000001135825628, createdTime=Thu Oct 17 07:51:42 CST 2024, time=2024-10-17, status=1, ipAttribution=日本), GetPortalCommentsPageByObjectIdResponse(id=2230967, encodeId=92e6223096e41, content=审稿速度:6.0 偏重的研究方向：转化医学 经验分享：9.26投稿一直new submission 20天了没动静，写了一次催稿信，没回复 10.15 写了撤稿，蹲后续, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b998153454, createdName=ms2000002105671892, createdTime=Tue Oct 15 08:19:11 CST 2024, time=2024-10-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2224693, encodeId=3fd12224693c9, content=请问下大伙这个杂志new manuscript要多长时间，我的已经12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44ca5480638, createdName=ms7000000631111361, createdTime=Sun Sep 08 14:44:25 CST 2024, time=2024-09-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2230765, encodeId=ef382230e658b, content=已经22天了还是new submission ，是什么情况呀，也太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80059409596, createdName=ms5000000686904291, createdTime=Mon Oct 14 09:43:06 CST 2024, time=2024-10-14, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2228040, encodeId=7a872228040df, content=偏重的研究方向：内科 经验分享：请问大家一审修回后under review一周又变成reviewers assigned这是为什么啊，是有个审稿人拒了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55475510121, createdName=beryllee, createdTime=Fri Sep 27 19:34:13 CST 2024, time=2024-09-27, status=1, ipAttribution=浙江省)]

2024-10-14 ms5000000686904291 来自黑龙江省

已经22天了还是new submission ，是什么情况呀，也太慢了

8 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2230093, encodeId=86b42230093c0, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;实验验证;生信分析 经验分享：已经10天了还是new submission，我真服了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b789465039, createdName=ms2000000351369451, createdTime=Thu Oct 10 09:17:34 CST 2024, time=2024-10-10, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2229455, encodeId=03602229455bd, content=9.24投稿，一直都是New Submission的状态，看大家好像都是New submission的状态持续了很久，这个到底是什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ed95231680, createdName=147a0654m16暂无昵称, createdTime=Sat Oct 05 22:12:13 CST 2024, time=2024-10-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2231705, encodeId=83fd2231e051f, content=3.26 New Submission； 3.29 Reviwerers Assigned; 4.18Reviwerers Assigned; 7.10 Reviwerers Assigned; 7.16 Reviwerers Assigned; 7.25 Reviews Completed; 8.5 Revision; 8.17 Back; 8.26 Under Review; 9.11 Reviews Completed; 9.16 Editor Assigned; 9.18 Accepted., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230904/40692e5b0b4845d79b7286fcdec4d98b/e529a33c15604ed0b99794e72bf3a6ac.jpg, createdBy=a29c4739753, createdName=Best wishes, createdTime=Sat Oct 19 13:06:15 CST 2024, time=2024-10-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2231068, encodeId=bbf122310687b, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：好慢呀，已经3周了都还是New Submission，不知道到底有没有处理稿件，Your research上都还查不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=617e5398444, createdName=ms8000002010343827, createdTime=Tue Oct 15 17:25:07 CST 2024, time=2024-10-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2231710, encodeId=96012231e10a7, content=投稿命中率:5.0 经验分享：9.27投稿，一直是new submission状态，10.19被拒，没有理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53579476156, createdName=ms3000000427064285, createdTime=Sat Oct 19 13:55:27 CST 2024, time=2024-10-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2231278, encodeId=c34422312e869, content=偏重的研究方向：肿瘤 经验分享：09/26 submission 10/15 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c67b9417863, createdName=ms7000001135825628, createdTime=Thu Oct 17 07:51:42 CST 2024, time=2024-10-17, status=1, ipAttribution=日本), GetPortalCommentsPageByObjectIdResponse(id=2230967, encodeId=92e6223096e41, content=审稿速度:6.0 偏重的研究方向：转化医学 经验分享：9.26投稿一直new submission 20天了没动静，写了一次催稿信，没回复 10.15 写了撤稿，蹲后续, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b998153454, createdName=ms2000002105671892, createdTime=Tue Oct 15 08:19:11 CST 2024, time=2024-10-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2224693, encodeId=3fd12224693c9, content=请问下大伙这个杂志new manuscript要多长时间，我的已经12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44ca5480638, createdName=ms7000000631111361, createdTime=Sun Sep 08 14:44:25 CST 2024, time=2024-09-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2230765, encodeId=ef382230e658b, content=已经22天了还是new submission ，是什么情况呀，也太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80059409596, createdName=ms5000000686904291, createdTime=Mon Oct 14 09:43:06 CST 2024, time=2024-10-14, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2228040, encodeId=7a872228040df, content=偏重的研究方向：内科 经验分享：请问大家一审修回后under review一周又变成reviewers assigned这是为什么啊，是有个审稿人拒了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55475510121, createdName=beryllee, createdTime=Fri Sep 27 19:34:13 CST 2024, time=2024-09-27, status=1, ipAttribution=浙江省)]

2024-09-27 beryllee 来自浙江省

偏重的研究方向：内科
经验分享：请问大家一审修回后under review一周又变成reviewers assigned这是为什么啊，是有个审稿人拒了嘛

9 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务